跳到正文
Moffitt Cancer Center· @MoffittNews · X·· 2026-04-21评分60
正文 · 原文

At #AACR26, Dung-Tsa Chen, PhD, highlights how early, low-grade side effects may serve as biomarkers to predict treatment response in advanced NSCLC. #MoffittAACR26
@AACR

热度 8 · 6 赞 · 0 回复 · 2 转发

来源:Moffitt Cancer Center · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org